Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. - Wikidata - awgldk - TriplyDB

Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis.

Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis.

http://www.wikidata.org/entity/Q34418687

about

Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?Treatment for amphetamine psychosis Khat use and neurobehavioral functions: suggestions for future studies Neurologic manifestations of chronic methamphetamine abuse Methamphetamine-associated psychosis.Epigenetic mediation of environmental influences in major psychotic disorders A review of the clinical pharmacology of methamphetamine Capacity building and collaborative research on cross-national studies in the Asian region BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation.Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort Methamphetamine enhances the development of schizophrenia in first-degree relatives of patients with schizophrenia.Current research on the epidemiology, medical and psychiatric effects, and treatment of methamphetamine use Drugs of abuse and increased risk of psychosis development.Long-term follow-up of patients treated for psychotic symptoms that persist after stopping illicit drug use.Management of methamphetamine abuse and dependence.Prevalence and clinical characteristics of psychotic versus nonpsychotic major depression in a general psychiatric outpatient clinic.Reaction time variability and related brain activity in methamphetamine psychosis.Current research on methamphetamine: epidemiology, medical and psychiatric effects, treatment, and harm reduction efforts The epidemiology of schizophrenia: replacing dogma with knowledge Behavioral regulation in methamphetamine abusers: an fMRI study.Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.Neurologic manifestations of chronic methamphetamine abuse.Methamphetamine psychosis: epidemiology and management Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure Methamphetamine-Associated Psychosis and Treatment With Haloperidol and Risperidone: A Pilot Study.Substance misuse and early psychosis.Substance use and abuse in first-episode psychosis: prevalence before and after early intervention Complex diagnostic and treatment issues in psychotic symptoms associated with narcolepsy Long-term outcomes in methamphetamine psychosis patients after first hospitalisation.Increased blood 8-hydroxy-2-deoxyguanosine levels in methamphetamine users during early abstinence.Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors.Oxidative stress status in recently abstinent methamphetamine abusers.N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges.Prenatal genetic counselling for psychiatric disorders.A systematic review of risk factors for methamphetamine-associated psychosis.Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia.Chronic methamphetamine psychosis after long-term abstinence in Japanese incarcerated patients.Analysis of association of clinical correlates and 5-HTTLPR polymorphism with suicidal behavior among Chinese methamphetamine abusers.Methamphetamine-related psychosis: an opportunity for assertive intervention and prevention.Environmental Risk Factors for Schizophrenia

P2860

Q21260315-23607EA9-0BEB-4A7C-898E-77BB30D4C32D Q24241011-1AC75624-C97E-4691-BD07-C9BDF2B7E27B Q24610235-70524EDE-CD7F-4805-BFE5-2402976DFB3B Q24624506-CEDD1380-7AA6-4BDB-9359-918437715A99 Q24632172-F8656D09-637A-4EF7-86ED-7151FBB4DDFC Q24652697-023B643A-EEB7-4405-A245-C95957FE01E0 Q28244252-27164108-2211-42EA-8554-221E04467099 Q30414573-C5C24F15-3EC4-476F-9070-F0FE722E4910 Q30453396-B6C5E64B-9F5A-4F20-907C-D01D1C46C6BB Q33599863-32988986-AFC5-471C-B1A6-62DEDF6A868B Q33836822-FAC0CE68-0EAA-4A14-A2E6-0EC64138E7D6 Q34154090-2D21BDA8-7E5A-4256-ACDB-FE4C84BE6B66 Q34290364-7D6693E9-09C2-48E8-B067-11AE1BA028ED Q34347477-81F0FA70-AE26-4645-ABCA-840059C7CB07 Q34565565-173F6A1C-918B-48EB-9AFC-3D35B5569146 Q35037187-A0D9ABAB-0EB7-4F3A-A7B5-18A839D22885 Q35044536-F9F383CA-89F9-4460-B684-DAFF3F6D2D6B Q35160984-4C9E772B-153B-441E-83C3-1C89F5421BBC Q35237282-C130A0CD-0A84-4061-B62C-4BCB33F7CD51 Q36674836-53A70F09-9676-46DB-888F-19E7D0164D58 Q37103392-72A1F13B-FE9F-463E-9366-EABA73ED3261 Q37150547-F5575399-BFD2-4ADB-A73A-78C5C46B187F Q37265315-9376C5AA-17DA-4EFE-87FF-630F9C7DEC4C Q37282162-34489D1C-0F9C-40FA-BF48-F10A98DA9F91 Q37396732-C9C3DEBE-A89D-4C3C-A7E5-4F8743EA96CC Q37419167-590A79CF-C30A-49A7-9A2A-8E42CAC3E8E8 Q37427095-6D77C1D9-EF65-4773-AC11-5D7C4E5987EA Q37590701-F30474CF-8E78-482D-9AC0-DCFBC985A46D Q37773412-02E68A4E-FDD1-4021-AE90-053CF126104F Q38654602-D8C75CE6-AD7B-4CCD-84B6-DAA62462202D Q39153958-35E70D49-DCB9-444B-8B5A-2D7D80775951 Q39462090-1EF01490-108C-4804-9547-97CF32ABCD8B Q46265873-33399B01-D23E-4483-906B-C35504F5CEE4 Q47972097-85DDCB8E-97C2-4DF2-816A-4D5692060D81 Q48233764-9D577745-5554-4612-B2FF-2556D051BB6F Q48306270-2E00CF7A-16C4-4366-A206-C3255F093085 Q51479034-D7393C80-99D1-4542-8702-F73C88399273 Q51737151-DE53D3B7-7739-458C-8F53-41773F5CC1F4 Q52311218-3CF922D2-2217-4AFB-A150-D93A052409E5 Q57403291-CE344651-D8FE-4C11-9D2B-B41487F7C9EE

P2860

Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis.

http://www.wikidata.org/entity/Q34418687

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Morbid risk for psychiatric di ...... rs with and without psychosis.

@ast

Morbid risk for psychiatric di ...... rs with and without psychosis.

@en

Morbid risk for psychiatric di ...... rs with and without psychosis.

@nl

type

label

Morbid risk for psychiatric di ...... rs with and without psychosis.

@ast

Morbid risk for psychiatric di ...... rs with and without psychosis.

@en

Morbid risk for psychiatric di ...... rs with and without psychosis.

@nl

prefLabel

Morbid risk for psychiatric di ...... rs with and without psychosis.

@ast

Morbid risk for psychiatric di ...... rs with and without psychosis.

@en

Morbid risk for psychiatric di ...... rs with and without psychosis.

@nl

P1433

Q34418687-EE3FC091-0F0E-4C57-AF1F-5C2420925896

P1476

Q34418687-3DD654D1-E482-43CC-B054-359F34F48A0A

P2093

Q34418687-44CF682C-7133-4AD6-94D4-0B0D54BE9954

Q34418687-5081AE8F-CFC5-47E5-A71C-0908E74AF5DF

Q34418687-5C1ECAAC-9469-4118-BA2E-A4A513BDFF34

Q34418687-CC064FC5-FDC5-4D87-85F8-141B81B0AF68

Q34418687-D8B5EC16-0EBD-443D-9372-33B49B404D23

P2860

Q34418687-298F2BB9-EC47-4D72-A472-259F25ACC35B

Q34418687-7A3C89D1-025E-447F-B314-67AA7C23201F

Q34418687-A65E719E-C69F-4A7D-837E-C847CE834ECB

Q34418687-B986CBBD-7478-46EC-94CD-6F686454E055

Q34418687-BB72DED4-ED17-4DAC-B98B-D985B8800234

Q34418687-CDA95D52-6455-44D4-A90B-9ADC23FC9EB1

Q34418687-D86E5648-082B-4791-9339-13B2679B6200

Q34418687-F48A05AA-D0CB-49EB-B04E-E3FC3809B7A6

P304

Q34418687-7F5EF7D2-3C28-49BB-8F37-506ECAB3A70C

P31

Q34418687-C8FC125B-192E-4306-AF3D-B978193410CE

P356

Q34418687-7920B9AD-6757-4645-A627-7D6D43A487F1

P433

Q34418687-5A346C63-66CC-4FB1-A253-9B91DAA8D3B2

P478

Q34418687-B35CF66D-B468-4D5D-8F91-C7256A3A2D6E

P50

Q34418687-A18948C6-297C-4563-B78D-3E3DFB926AC7

P577

Q34418687-F5F4D2EB-39BD-4D40-975C-712C4E0B14BE

P5875

Q34418687-7C6F1D44-DC8A-4EB7-A271-AFB01A76F45C

P698

Q34418687-5A24A983-29E4-4001-A224-2BA544AB893A

P921

Q34418687-CD9BC408-B1E1-45AB-89D0-60772AA07C2C

P356

P1433

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

P1476

Morbid risk for psychiatric di ...... rs with and without psychosis.

@en

P2093

Chih-Ken Chen

http://www.w3.org/2001/XMLSchema#string

David Ball

http://www.w3.org/2001/XMLSchema#string

El-Wui Loh

http://www.w3.org/2001/XMLSchema#string

Pak C Sham

http://www.w3.org/2001/XMLSchema#string

Shih-Ku Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.

Outcome and familial psychopathology in schizophrenia.

A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder.

Psychoses precipitated by psychotomimetic drugs. A follow-up study.

Neurobiological vulnerability to low-dose amphetamine psychosis.

Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients.

The family history approach to diagnosis. How useful is it?

Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition.

P304

87-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJMG.B.30187

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

136B

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7849489

http://www.w3.org/2001/XMLSchema#string

P698

15892150

http://www.w3.org/2001/XMLSchema#string

P921